Micro- and nanoplastics are tiny fragments of plastic pollutants, often invisible to the naked eye, that infiltrate environmental compartments—marine, freshwater, and terrestrial alike. Their impact on biological systems is multifaceted, affecting organisms at cellular, physiological, and population levels. Toxicologists and ecologists have struggled to converge on standardized approaches that can accurately determine the hazard posed by these particles. The traditional criteria and evaluation tools, while robust for classical chemical toxicity assessments, fall short when confronted with the unique challenges presented by plastic particulates—issues like particle shape, size distribution, chemical leachates, and physical abrasion effects.

The innovative frameworks, SciRAPplastic and plasticCRED, carve a methodological path forward by tailoring existing scientific evaluation tools to better suit the peculiarities of micro- and nanoplastics studies. SciRAPplastic adapts from the broader SciRAP tool—originally developed for chemical toxicity study assessments—morphing it into an evaluative lens sensitive to plastic-specific parameters. Meanwhile, plasticCRED integrates expert judgment and a scoring system to quantify the reliability and relevance of studies, enabling researchers and policymakers to sift through a growing body of research with enhanced confidence and clarity.

One of the pivotal strengths of this dual-tool approach lies in its meticulous consideration of particle characterization. The authors emphasize that without rigorous, transparent particle analysis—detailing attributes such as polymer type, surface chemistry, and particle size—results can be fundamentally misleading. Both SciRAPplastic and plasticCRED mandate exhaustive reporting and verification of these parameters, reinforcing the importance of methodological stringency. Consequently, these tools help detect studies that may rely on questionable or poorly described particle materials, thereby preventing propagation of inaccuracies in the scientific discourse.

Moreover, assessing exposure and dose metrics presents a venerable challenge unique to micro- and nanoplastics research. Unlike soluble chemicals, plastics’ physical attributes modulate their interaction with organisms in complex ways. SciRAPplastic and plasticCRED guide evaluators to scrutinize whether studies accurately quantify exposure concentrations, account for particle aggregation or sedimentation, and employ realistic environmental scenarios. This scrutinous evaluation fosters data interpretation that mirrors ecological realities, making toxicity outcomes more predictive of actual environmental risks.

Tightly coupled with exposure assessment is the critical issue of biological endpoints. The tools embed criteria that evaluate the biological relevance of chosen endpoints, ensuring that biomarkers or physiological responses measured truly reflect toxic effects attributable to micro- and nanoplastics. For example, endpoints related to oxidative stress, inflammation, or reproductive impairment are preferentially endorsed if they align with recognized adverse outcome pathways. This alignment maximizes the translational impact of studies—linking mechanistic insight to potential population-level consequences.

Statistical robustness and transparency feature prominently in the frameworks’ design. Given the variability inherent in particle preparation and biological systems, studies must apply appropriate statistical models and clearly state their assumptions and limitations. SciRAPplastic and plasticCRED challenge studies with incomplete or opaque statistical treatment, highlighting the necessity of replicability and methodological honesty. This facet ensures that downstream meta-analyses and risk assessments are built upon a foundation of credible, high-quality data.

Implementing SciRAPplastic and plasticCRED offers transformative benefits beyond academic rigor. Regulators and environmental managers can leverage these evaluation tools to prioritize high-caliber studies and avoid the pitfalls of over- or underestimating ecological risks. As micro- and nanoplastics regulatory frameworks emerge worldwide, having well-founded criteria for study inclusion establishes a clearer evidence base for policymaking. This, in turn, accelerates decision-making processes and increases public trust in environmental governance.

The research community will also find these frameworks vital in harmonizing interdisciplinary efforts. Micro- and nanoplastics research intersects material science, toxicology, ecology, and analytical chemistry. By providing a common evaluative lexicon, SciRAPplastic and plasticCRED facilitate cross-domain dialogue and integration, propelling forward a more unified scientific narrative. This consensus-building is essential for advancing knowledge translation into effective mitigation strategies.

Importantly, due to the dynamic evolution of micro- and nanoplastics research, these frameworks are envisioned as living tools, capable of adaptation with accruing scientific insights. The authors underscore that continuous validation and refinement through community feedback, empirical testing, and harmonization with emerging standards are indispensable. This forward-leaning approach reflects a modern scientific ethos—remaining flexible in the face of complexity while striving for methodological excellence.

The development of SciRAPplastic and plasticCRED represents a significant stride towards standardizing how we assess the environmental and human health risks posed by micro- and nanoplastics. Their introduction addresses a glaring gap: the absence of customizable, rigorous evaluation mechanisms tailored to this distinctive class of pollutants. As microplastic contamination escalates and penetrates deeper into ecosystems and food webs, scientific tools must evolve commensurately to provide reliable hazard and risk assessments.

Beyond the scientific milieu, these tools carry profound implications for societal awareness and policy evolution. With plastic pollution often capturing public attention through alarming visuals and narratives, having substantiated scientific assessments is critical to inform balanced interventions. SciRAPplastic and plasticCRED thus serve as gatekeepers, elevating the quality of scientific evidence communicated to the public and policymakers, ensuring that responses to plastic pollution are proportionate and evidence-based.

This innovation is also poised to inspire further technological and methodological innovation in ecotoxicology. Other contaminants with particulate behavior—like engineered nanomaterials or atmospheric dust—could benefit from similar tailored assessment frameworks. The conceptual blueprint laid out by Due and colleagues opens avenues for broadening the toolkit for environmental hazard evaluation in a variety of contexts.

Ultimately, the arrival of SciRAPplastic and plasticCRED signifies a pivotal evolution in environmental toxicology methodology, aligning scientific rigor with ecological complexity. Their adoption promises to sharpen our understanding of the effects of micro- and nanoplastics, fostering more accurate predictions of their impacts and guiding focused actions to curb their threat. As the global scientific community rallies to confront the pervasive issue of plastic pollution, these tools stand out as critical instruments in our arsenal.

Due, Beronius, Baun, and the interdisciplinary team behind this endeavor have provided not merely evaluation tools but a framework for unifying and accelerating micro- and nanoplastics research. Their contribution offers hope for a future where scientific evaluations are not hindered by methodological frailty but propelled by consensus, clarity, and confidence—ushering in more actionable insights and effective environmental safeguarding for generations to come.

Article References:

Due, I., Beronius, A., Baun, A. et al. SciRAPplastic and plasticCRED: tailoring existing tools to assess micro- and nanoplastics (eco)toxicity studies.
Micropl.&Nanopl. (2025). https://doi.org/10.1186/s43591-025-00151-8

Microplastics are pervasive pollutants, found virtually everywhere—from ocean depths to urban landscapes—and their impact on the environment and health is alarmingly multifaceted. These tiny plastic fragments, typically less than 5 millimeters in size, originate from the degradation of larger plastic debris or from manufactured products such as microbeads in cosmetics. Because of their durability and small size, microplastics are readily ingested by a vast range of organisms, from plankton to mammals, entering fragile food webs and raising concerns about bioaccumulation and toxicological effects. However, the study of their toxicity has been hampered by methodological challenges, heterogeneity in particle composition and size, and varying environmental contexts.

Enter ToMEx 2.0, an advanced computational platform designed to integrate diverse datasets on microplastic characteristics—such as polymer type, size, shape, and associated chemical additives—with experimental toxicity data from cellular to organismal levels. By harnessing state-of-the-art machine learning algorithms and high-throughput screening data, the tool provides predictive models that quantify the toxic potential of different microplastic variants under varying environmental conditions. This capability represents a paradigm shift, enabling toxicologists and ecologists to move from correlative studies to mechanistic insights and causal predictions.

Structurally, ToMEx 2.0 builds upon its predecessor by incorporating enhanced databases that cover a broader spectrum of plastic polymers, including emerging biodegradable alternatives and nanoplastics, which are even smaller particles with distinct behavioral and toxicological profiles. The system leverages advanced computational chemistry techniques to simulate interactions between microplastic surfaces and cellular membranes, offering molecular-level resolutions that inform on particle adhesion, penetration, and cellular uptake mechanisms. These detailed simulations contribute to a mechanistic understanding of how microplastics induce cytotoxicity, oxidative stress, inflammation, and genotoxic effects.

Importantly, ToMEx 2.0 recognizes the heterogeneity of microplastic contaminants across environmental compartments—freshwater, marine, and terrestrial systems—and models differential bioavailability and toxicity accordingly. This ecological context sensitivity is critical because exposure pathways and organism susceptibilities vary dramatically across ecosystems. For instance, marine filter feeders encounter microplastics in suspended particulate matter, whereas terrestrial organisms may experience ingestion through contaminated soils or atmospheric deposition. By integrating biotic and abiotic factors, ToMEx 2.0 affords higher ecological validity to toxicity predictions.

The advent of ToMEx 2.0 also addresses the growing concern over chemical additives and sorbed pollutants associated with microplastics, which can leach harmful substances such as phthalates, heavy metals, and persistent organic pollutants. These co-contaminants often intensify the toxicological burden, yet their interactions with microplastic particles have remained poorly characterized. Through coupling toxicity datasets with chemical speciation profiles, ToMEx 2.0 disentangles additive versus synergistic toxic effects, providing clarity on compound-specific hazards in composite microplastic pollution scenarios.

Beyond the scientific community, the application of ToMEx 2.0 bears significant implications for environmental policy and public health. Regulators tasked with managing plastic pollution now have a powerful decision-support tool that can prioritize high-risk plastic types and inform mitigation strategies. For example, industry stakeholders can utilize insights from ToMEx 2.0 to redesign plastic materials with reduced ecological footprints, aligning with circular economy principles that emphasize sustainable production and waste reduction.

Moreover, the platform paves the way for standardized toxicity assessments by advocating harmonized protocols across laboratories worldwide, fostering data comparability and reproducibility. By offering open-access modules and user-friendly interfaces, ToMEx 2.0 democratizes microplastic research, enabling even resource-limited institutions to engage in robust toxicity evaluations and contribute to global data repositories.

Technological innovations underpinning ToMEx 2.0 include synergistic integration of multi-omics data—genomics, transcriptomics, proteomics, and metabolomics—captured from organisms exposed to microplastics. This systems biology approach elucidates cellular pathways perturbed by plastic particles, revealing molecular signatures indicative of stress responses, immune activation, and metabolic dysregulation. These biomarkers enhance the predictive accuracy of ToMEx 2.0, linking exposure metrics to realistic biological outcomes.

Notably, ToMEx 2.0 also incorporates temporal dynamics by simulating chronic exposure scenarios, thereby addressing often overlooked long-term effects of low-dose microplastic ingestion. This aspect is fundamental, given that environmental exposures are rarely acute and the accumulation of microplastics over time may drive subtle but consequential physiological changes, contributing to developmental delays, reproductive impairments, and susceptibility to diseases.

In the context of nanoplastics, ToMEx 2.0 offers pioneering insights into their unique ability to traverse biological barriers, reaching intracellular organelles and even the central nervous system in animal models. The tool’s predictive capacity in this domain is particularly crucial as the prevalence of nanoplastics is increasing through continuous degradation processes and novel manufacturing techniques, yet toxicity data remain sparse.

The interdisciplinary framework of ToMEx 2.0 facilitates collaborations across materials science, toxicology, ecology, and computational biology, encouraging integrative approaches rather than siloed investigations. Its predictive models are continuously refined through iterative feedback loops, incorporating emergent experimental findings and environmental monitoring data, fostering dynamic adaptability to evolving research needs and pollution patterns.

Critically, Hampton and colleagues emphasize that ToMEx 2.0 is not merely a computational curiosity but a transformative asset for urgent environmental stewardship. By enabling precise identification of hazardous microplastic types and exposure pathways, it empowers evidence-based interventions, targeted remediation efforts, and informed policymaking that can mitigate the growing global microplastic crisis.

Looking ahead, the research team envisions expanding ToMEx’s geographic and taxonomic scope, integrating citizen science data streams and real-time sensor networks, thereby enhancing spatial-temporal resolution of microplastic pollution assessments. Such advancements will augment early warning capabilities and support rapid response strategies to emerging ecological threats.

In sum, the launch of ToMEx 2.0 marks a watershed moment in microplastic toxicity research by melding computational sophistication with ecological realism and biological relevance. As microplastic contamination escalates worldwide, tools like ToMEx 2.0 will be vital in deciphering the complex interplay between synthetic particles and living systems, facilitating sustainable solutions for plastic pollution mitigation and environmental health protection.

Subject of Research: Microplastic toxicity and computational modeling tools for environmental toxicology

Article Title: The Toxicity of Microplastics Explorer (ToMEx) 2.0

Article References:
Hampton, L.M.T., Wyler, D.B., Almroth, B.C. et al. The Toxicity of Microplastics Explorer (ToMEx) 2.0. Micropl.& Nanopl. 5, 38 (2025). https://doi.org/10.1186/s43591-025-00145-6

Image Credits: AI Generated

The liver’s critical role in detoxifying the bloodstream makes it exceptionally vulnerable to toxic insults from PFAS. These “forever chemicals,” as they are often termed due to their resistance to degradation, accumulate over many years, raising concerns about long-term health consequences including liver damage and metabolic disruptions. Despite epidemiological evidence linking PFAS exposure to liver abnormalities, including steatosis and cancer, the precise cellular and molecular mechanisms remained incompletely understood until now, largely due to limitations in traditional animal and cell culture models.

To overcome these challenges, researchers turned to human liver spheroids—a sophisticated three-dimensional culture system that closely mimics the architecture and microenvironment of the human liver. Made from cells pooled from multiple donors, these spheroids preserve critical cell-cell interactions that drive normal liver functions and pathological responses. This platform allowed for a nuanced investigation into the effects of four prevalent PFAS compounds—perfluorooctanoic acid (PFOA), perfluorohexanesulfonic acid (PFHxS), perfluorooctanesulfonic acid (PFOS), and perfluorononanoic acid (PFNA)—each tested independently to discern their unique toxicity profiles.

After a continuous seven-day exposure of liver spheroids to these PFAS compounds, researchers employed advanced single-cell RNA sequencing to unravel gene expression changes at an unprecedented resolution. This technique revealed that while all four PFAS disrupt immune signaling pathways and interfere with intercellular communication—processes essential for liver homeostasis—their downstream effects diverged significantly. For instance, PFOA and PFHxS both promoted abnormal fat accumulation in liver cells, yet they achieved this through distinct mechanisms: PFOA stimulated de novo lipogenesis, increasing fat synthesis, whereas PFHxS inhibited fat metabolism, causing retention of lipids within cells.

Conversely, exposure to PFOS and PFNA led to gene expression patterns linked to oncogenic transformation. Notably, PFNA demonstrated a pronounced effect in activating pathways associated with inflammation, oxidative stress, and DNA repair mechanisms—hallmarks of cellular stress that can precipitate malignant transformation. The startling discovery that 61.3% of PFNA-exposed liver cells exhibited cancer-related gene signatures underscores the grave risk this compound poses to liver health, potentially accelerating the progression towards hepatocellular carcinoma.

Intriguingly, the study uncovered sex-specific differences in liver cell responses to PFAS exposure. Female-derived liver cells exhibited heightened sensitivity to PFOA, whereas male-derived cells were more affected by PFOS. These findings hint at underlying biological pathways modulated differently across sexes, suggesting the need for sex-informed strategies in both risk assessment and therapeutic development. Such differential susceptibility could be rooted in hormonal influences, enzyme expression profiles, or genetic regulatory networks that modulate PFAS metabolism and cellular stress responses uniquely in males and females.

The implications of this research extend far beyond the laboratory. By illuminating the precise cellular pathways disrupted by individual PFAS compounds, the study provides a critical foundation for the design of targeted interventions. Some pharmaceutical agents that modulate lipid metabolism and inflammation—already approved by the U.S. Food and Drug Administration—emerge as promising candidates for repurposing to ameliorate PFAS-induced liver toxicity. This represents a pivotal step towards translating mechanistic insights into clinical therapies that can reduce the burden of PFAS-related liver diseases.

Yet, despite therapeutic optimism, the researchers emphasize that prevention remains paramount. Reducing PFAS exposure is critical given their pervasive presence and persistent nature. They advise practical measures such as consuming filtered water and avoiding products coated with PFAS, including nonstick cookware. Although regulatory efforts are underway globally, immediate individual actions offer a necessary line of defense against these insidious chemicals, whose harm continues to unfold silently within our bodies.

This investigation is part of the Southern California Superfund Research and Training Program for PFAS Assessment, Remediation and Prevention (ShARP Center), a multidisciplinary NIH-funded initiative committed to addressing the environmental and health challenges posed by PFAS contamination. By fostering collaboration across toxicology, environmental science, and public health, the ShARP Center aims to generate actionable knowledge and innovative solutions that can safeguard communities affected by PFAS pollution.

Future directions for this research involve exploring the combined effects of multiple PFAS compounds, reflecting real-world exposure scenarios where humans encounter complex mixtures rather than single substances. This line of inquiry is crucial because PFAS mixtures may exhibit synergistic or additive toxicities that differ from individual chemicals, further complicating risk assessment and regulatory standards. Understanding these interactions at the granular cellular level will be key to refining safety guidelines and developing effective mitigation strategies.

The technical achievements in this study—particularly the use of multi-donor human liver spheroids paired with single-cell transcriptomics—represent a breakthrough for toxicological research. This approach enables scientists to disentangle heterogeneous cellular responses, map molecular pathways with fine detail, and capture subtle variations linked to donor sex or genetic background. Such methodological innovations are setting new standards for environmental health research, transcending the limitations of animal models and traditional cell cultures.

As PFAS contamination continues to be a pressing environmental health issue worldwide, this research highlights the urgent need for informed public health policies and consumer awareness. The distinct molecular fingerprints left by different PFAS chemicals in liver cells not only clarify their individual toxicities but also underscore the complexity of their impact on human health. Accurate, mechanistic knowledge is indispensable for crafting nuanced regulations that protect vulnerable populations while guiding the development of medical interventions.

In sum, this comprehensive study advances our understanding of how perfluoroalkyl substances sabotage liver health at the most fundamental biological levels. Through innovative research techniques and a focus on translational impact, the USC team has transformed the opaque landscape of PFAS toxicity into a clearer map of cellular disruption, risk, and potential remedy. Their work will resonate across toxicology, medicine, and environmental science communities for years to come, fueling efforts to combat the global challenge posed by these persistent pollutants.

Subject of Research: Cells

Article Title: Assessing the impact of perfluoroalkyl substances on liver health: a comprehensive study using multi-donor human liver spheroids

News Publication Date: 5-Sep-2025

Web References:
https://www.sciencedirect.com/science/article/pii/S0160412025005148
http://dx.doi.org/10.1016/j.envint.2025.109763

References:
Maretti-Mira, A. C., Golden-Mason, L., Matsuba, C., Wang, Y., Salomon, M. P., Setiawan, V. W., & Chatzi, L. (2025). Assessing the impact of perfluoroalkyl substances on liver health: a comprehensive study using multi-donor human liver spheroids. Environment International, [DOI:10.1016/j.envint.2025.109763].

Keywords:
Liver damage, Liver cancer, Metabolic disorders, Chemical pollution, Water pollution, Pollutants, Fatty liver disease